Crafting a Personalized Prognostic Model for Malignant Prostate Cancer Patients Using Risk Gene Signatures Discovered through TCGA-PRAD Mining, Machine Learning, and Single-Cell RNA-Sequencing
Background: Prostate cancer is a significant clinical issue, particularly for high Gleason score (GS) malignancy patients. Our study aimed to engineer and validate a risk model based on the profiles of high-GS PCa patients for early identification and the prediction of prognosis. Methods: We conduct...
Main Authors: | Feng Lyu, Xianshu Gao, Mingwei Ma, Mu Xie, Shiyu Shang, Xueying Ren, Mingzhu Liu, Jiayan Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/13/12/1997 |
Similar Items
-
The Prognostic Signature and Therapeutic Value of Phagocytic Regulatory Factors in Prostate Adenocarcinoma (PRAD)
by: Shiyong Xin, et al.
Published: (2022-05-01) -
Identification of a Costimulatory Molecule-Related Signature for Predicting Prognostic Risk in Prostate Cancer
by: Shengdong Ge, et al.
Published: (2021-08-01) -
Effects of RNA Binding Proteins on the Prognosis and Malignant Progression in Prostate Cancer
by: Xiaoliang Hua, et al.
Published: (2020-10-01) -
Novel cuproptosis-related long non-coding RNA signature to predict prognosis in prostate carcinoma
by: Xiaofeng Cheng, et al.
Published: (2023-01-01) -
Utilization of hypoxia-derived gene signatures to predict clinical outcomes and immune checkpoint blockade therapy responses in prostate cancer
by: Minhua Chen, et al.
Published: (2022-08-01)